Dr. Michael L. Sand, DO

Dr. Sand practices at Sanford Fargo Hospice in Fargo, North Dakota.

Dr. Sand's NPI, 1154343705, was assigned on July 24, 2006. Dr. Sand graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 1987. Dr. Sand holds Minnesota license 32265.

Dr. Sand's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.

Dr. Sand's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Sand is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Sand to 3 more hospitals, 3 skilled nursing facilities, 2 home health agencies, 2 hospices and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sand practices, 13 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sand's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sand is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sand's licenses on file in 2 states: Minnesota and North Dakota.

CMS data shows 1,509 Medicare services from Dr. Sand across 6 procedure codes in 2024, for 576 Medicare patients. Medicare paid $65,882 for them.

CMS counts 576 Medicare patients who saw Dr. Sand in 2024. The largest group is 75 to 84, with 187 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sand's median patient age at 78, with 43% women.

In 2024, Dr. Sand wrote 15,117 Medicare Part D claims for 1,024 patients. 87% of them were for generic drugs. CMS names the drug for 14,261 of them, across 168 drugs with 11 or more claims each, at $1,090,149 in total drug cost. In 2023, CMS named 14,560 claims across 181 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Sand for performance year 2024, reported as part of a group. Dr. Sand accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Sand from 2 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $61.

Dr. Sand graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 1987.